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We tested a new bedside method to determine the function
of native arteriovenous fistula in 16 patients performed
during hemodialysis without stopping the treatment. We
initially measured vascular access flow (Qa) in each patient
using the Transonic HD01plus device. We then measured the
pressure in arterial and venous drip chambers at different
blood pump flow rates (Qbset¼ 0, 50, 100, 250, 300, 350 ml/
min). The intravascular blood pressure gradient (Pf) between
arterial and venous puncture sites was estimated by a
mathematical model. Pf was positive for low Qbset, but
became negative when Qbset overcame the threshold value
(QInv). Such critical flow showed a high correlation with Qa,
even if it was systemically lower. Computer analysis of fluid
dynamics showed that when the blood pump flow overcame
the QInv threshold, a critical transition from laminar flow to
vortex circulation took place downstream of the venous
needle, causing a dangerous shearstress on the vessel wall.
Our results show that QInv provides an indication of the
maximal blood pump flow rate needed to be reached to
maximize blood flow supply in order to limit hemodynamic
stress on the vascular access.
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Vascular access (VA) is commonly recognized as one of most
critical issue of the hemodialysis treatment.1 The failure of
hemodialysis VA and the related complications are one of the
main causes of discomforts for patient and access morbidity
accounts for more than 20% of hospitalization of hemodia-
lysis patients. Moreover, the cost associated with VA care
represents at least 15% of total spending for dialysis patients.2
Methods to prevent VA failure are awaited.
Clinical practice guidelines3 suggest the VA periodic
examination for early recognition of malfunctioning and
for preventing incipient impeding failure. Several procedures
have been proposed for VA assessment during the hemodia-
lysis treatment (bedside methods).4–8 These procedures
include recirculation measurements, dynamic and static
pressure monitoring and VA blood flow (Qa) measurements.
In arterio-venous fistulas (AVF) recirculation and venous
pressure measurements exhibit low sensitivity and specificity
for the prediction of stenosis as well as thrombosis. Methods
based on Qa determination appear to be superior, sub-
stantiating their common use both for AVF and for arterio-
venous grafts.9 Qa measurements by Doppler are uncommon,
whereas the ultrasound dilution technique proposed by
Krivitski10 is widespread. As a disadvantage, dilution
technique needs time-consuming procedures (several min-
utes) because of calibration, reversal of bloodline and
releasing of saline bolus. Moreover, it requires an additional
device (for example, Transonic).11
To overcome such limiting aspects, we developed a novel
method to estimate an index, called QInv, for the VA
characterization, which does not require either pause of
treatment or external maneuvers. The method combines the
measure of the pressure in the drip chambers along the
extracorporeal circulation with the perturbation of extra-
corporeal blood flow (Qb) produced by changing the rate of
the dialysis machine blood pump. As an advantage, the
method can be integrated in the artificial kidney to realize an
automatic system for the online VA monitoring not requiring
any operator intervention. The primary goal of this study was
to compare the index QInv with the Qa measured using
ultrasound dilution technique. The secondary goal was to
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combine the in vivo measurements and computational fluid
dynamics (CFD) simulations of VA hemodynamics to
interpret the experimental results and to identify critical
conditions of blood flow withdrawal and reinfusion that can
promote damages on the VA vessel walls.
RESULTS
Patients recruited for the study exhibited a wide range of Qa
values (Table 1). In eight patients Qa was greater than 600 ml/
min with a maximum value of 1520 ml/min, whereas it was
lower in the remaining eight patients. Importantly, in five of
these eight patients, access flow was critically low
(Qap360 ml/min) with a minimum of 115 ml/min. Qa was
measured in each study session at the beginning of the
experimental procedure (see Materials and Methods for
details). After measuring Qa, different Qb values were
imposed by changing the blood pump flow rate of the
dialysis machine (Qbset¼ 250, 50, 0, 50, 100, 150, 200, 250,
300, 350 ml/min). During the whole experiment, no adverse
events related to the study protocol occurred. Systemic
arterial pressure as well as heart rate remained stable in all
patients. Except for one patient (Table 1) no access
recirculation was observed. Moreover, the actual flow Qb
measured by Transonic resulted systematically lower than the
nominal value Qbset (Figure 1).
For each setting of Qb, the pressures in the extracorporeal
arterial (Pam) and venous (Pvm) drip chambers of extra-
corporeal circulation were measured. Intravascular blood
pressures at arterial (Paf) and venous (Pvf) puncture sites
were then estimated (see Materials and Methods; Eqs. 4–7)
and pressure drop between arterial and venous sites was
calculated as Pf¼ PafPvf. An example of pressures determi-
nation as a function of Qb is shown in Figure 2.
In principle, pressure drop Pf depends on the blood flow
between arterial and venous puncture sites, thus Pf should be
correlated with the access flow Qa (see Materials and
Methods). Actually, Pf evaluated at Qbset equal to 0 ml/min
(PfQbset¼ 0 ml/min) showed a poor correlation (R
2¼ 0.25) with
Qa (Figure 3a). The correlation between Pf and Qa increased
when Qbset was not null. The values of Pf with the highest
level of correlation (R2¼ 0.53) was found for Qbset equal to
250 ml/min (see Figure 3b). Importantly, with the exception
of two cases (pat15 and pat16), in the sessions with
Qao800 ml/min the pressure PfQbset¼ 250 ml/min was negative,
whereas in the sessions with Qa4800 ml/min, PfQbset¼ 250 ml/min
resulted positive (Figure 3b).
Besides the relationship with the blood flow, Pf also
depends on the hydraulic resistance between the puncture
Table 1 | Main information collected during the QInv assessment
BP(Syst/Diast; mm Hg) HR (bpm) Hcta (%) Hctv (%) Qa (ml/min) QInv (ml/min)
Pat01 143/73 88 31.8 32.5 500 175
Pat02 144/70 58 34.5 36.5 305 45
Pat02 150/80 60 40.7 42.4. 310 58
Pat03 132/72 83 38.5 40.0 990 270
Pat04a 127/70 56 32.1 34.0 280 191
Pat04a 125/70 60 33.8 35.3 115 9
Pat05 125/87 88 34.0 35.5 840 225
Pat06 140/85 65 35.5 35.7 1030 239
Pat06 127/77 66 35.3 37.3 990 258
Pat07 112/70 82 28.7 28.9 360 97
Pat08 170/77 67 37.3 41.0 1250 300
Pat09 100/65 88 32.3 33.3 450 191
Pat10 120/77 84 31.0 32.0 1130 306
Pat11 105/70 74 34.4 37.0 550 213
Pat12 185/90 68 28.5 30.3 1500 320
Pat13 125/70 62 25.8 27.9 1520 342
Pat14 130/80 66 32.4 34.6 1480 448
Pat15 112/80 83 35.3 37.8 235 168
Pat16 140/60 52 32.9 35.0 235 252
Mean±s.d. 132±21/75±8 72±12 33.4±3.6 35.1±3.9 740±481 216±110
Min–max 185/90100/65 56–88 25.8–40.7 27.9–42.4 115–1520 9–448
BP, blood pressure; Diast, diastolic pressure; Hctv, haematocrit in the venous line; Hcta, haematocrit in the arterial line; HR, heart rate; Qa, access flow by Transonic; QInv,
inversion flow (see paragraph Access flow estimation method); Syst, systolic pressure.
aPatient with access recirculation of 20%.
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Figure 1 | Comparison between nominal set-point and actual
values of extracorporeal blood flow. Symbols: Qb, blood flow in
the extracorporeal circulation (m±std, n¼ 16) measured by
TransonicTM for each nominal blood flow set, Qbset, imposed by
changing the rate of blood pump on the dialysis machine. The
identity line (continuous line) is shown as well.
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sites (Eq. 3 in Materials and Methods). This resistance can
significantly change when comparing different patients. To
minimize the influence of such intersubject variability, we
considered the quantity QInv, that is, Qb value at which Pf
changes its sign from positive to negative. Theoretically, Pf
inverts the sign when all the access flow upstream to the
arterial needle is sucked up in the extracorporeal circulation,
that is, when Qb is equal to Qa. In this condition, the
resistance between the puncture sites should play a minimal
role on Pf. The value of QInv was analytically calculated by
fitting the experimental points Pf vs Qb with a second order
polynomial equation and then computing QInv as the value of
Qb for which Pf becomes zero (as example see Figure 2c). In
all the 19 sessions the reliability of the second order
polynomial fitting was high (R2 40.75) and a value for QInv
was calculated (see Table 1). Notably, QInv showed a high
correlation (R2¼ 0.72) with respect to Qa (Figure 4). In
particular, QInv was greater than 200 ml/min when
Qa4500 ml/min (10 sessions), whereas QInv was lower than
200 ml/min for Qao500 ml/min (8 sessions). Only in one
session (pat 16) QInv, was higher than 200 with Qa o500 ml/
min. Notably, two patients (Pat04 and Pat02) with lowest
QInv, (9 ml/min and 45 ml/min) went on to develop a distal
occlusion with access failure after 1 (Pat4) and 6 (Pat2)
months after the end of the study.
CFD simulations
The observation of a critical threshold (QInv) systematically
lower than the respective Qa was unexpected. To enlighten
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Figure 2 | Example (pat01) of arterial (o) and venous (*) blood
pressures in extracorporeal line (Panel a) and vascular access
(Panel b) at different rate of extracorporeal blood flow.
Intravascular arterial-venous pressure drop and QInv estimation by
parabolic fitting (Panel c). Symbols: Qb, blood flow in the
extracorporeal circulation measured by TransonicTM; Pam and Pvm,
experimental pressures in the arterial and venous drip chambers;
Paf and Pvf pressures in the arterial and venous access points
calculated by the Eq.s 4 e 5 (see Methods); Pf¼ PafPvf gradient of
pressure between arterial and venous access points; QInv, value of
Qb for which quadratic curve fitting Pf is equal to zero.
y=0.0022*x–0.22
R2=0.25, N=19
25
20
15
10
5
0
–5
–10
–15
–20
–25
P f
 Q
bs
et
=2
50
 m
l/m
in
 
[m
mH
g]
y=0.023*x–20.88
R2=0.53, N=19
Qa [ml/min]
0 200 400 600 800 1000 1200 1400 1600
Qa [ml/min]
0 200 400 600 800 1000 1200 1400 1600
8
6
4
2
0
–2
P f
 
Q
bs
et
=0
 m
l/m
in
 
[m
mH
g]
Figure 3 | Intravascular arterial-venous pressure drop
compared with access flow for extracorporeal flow equals to 0
ml/min (Panel a) and equals to 250 ml/min (Panel a). Symbols:
Pf , gradient of pressure between arterial and venous access
points; Qbset, blood flow set on the blood pump of the artificial
kidney; Qa, access flow.
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Figure 4 | Inversion flow compared with access flow. One point
corresponds to a patient of Table 1. Linear regression (dotted line)
between QInv and Qa. Symbols: QInv, inversion flow: value of Qb for
which quadratic curve fitting Pf is equal to zero; Qa, access flow.
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this aspect we resort to a CFD analysis assuming the
hemodynamics in VA of Pat 01 as an explicative case of
population under study. Intravascular pressures predicted by
CFD analysis were validated by comparing (Figure 5) the
pressure computed in the inlet face of arterial needle with the
experimental Paf and the pressure computed in the outlet face
of venous needle with the experimental Pvf. CFD predictions
and measurements were in good agreement and the inversion
of Pf was at similar Qb value (about 170 ml/min). The blood
velocity fields downstream to the venous needle computed
for Qb¼ 150 and 300 ml/min were considered to explain the
change of sign in the pressure drop Pf. Despite the blood flow
in the section downstream to the needles being the same
(Qa¼ 500 ml/min), hemodynamics were significantly differ-
ent, especially in the nearness of venous puncture site
(Figure 6). In particular, for Qb¼ 300 ml/min, a zone with
reversal flow was highlighted downstream to the puncture
site, where Qb impacts the main stream (z¼Dv). More
specifically, recirculation occurred near to the upper wall
(y axis 40), whereas the blood velocity near to the bottom of
the vessel (y axis o0) significantly increased. The vortex
circulation extended for about 3 cm downstream to the
puncture site (see Figure 6) but it did not involve the flow
pumped in arterial needle. Axial velocity component
(z-velocity) was critically high (more than 3.0 m/s) and the
Reynolds number (Re¼ 1200) was close to the values for
which the laminar flow could vanish and turbulence takes
place. The vortex area identified the vascular region where the
vessel wall was maximally stressed. In particular, on the side
where reinfusion stream hit against the bottom wall
(see Figure 6) the peak value for the shear stress calculated
by CFD simulations was about 114 N/m2, whereas in the
opposite side where reversal flow takes place wall shear stress
was less than 5 N/m2, thus causing a very high wall stress
gradient.
DISCUSSION
Vascular access plays a pivotal role for quality of treatment
and clinical outcome of dialysis patients. Several techniques
have been proposed to assess VA functionality (for a review
see references9,12), nevertheless the optimal method has not
been identified yet, especially for AVF. Direct measurement of
Qa gives a useful indication on the amount of blood volume
supplied by the access. However, Qa measurement requires
complex operating procedures, which cannot be automati-
cally performed and it is not informative on the matching
between VA and extracorporeal circulation. Pressures mea-
surement in the extracorporeal circulation has been also used
to characterize VA adequacy. Pressure in the external
bloodlines potentially account for the impact of extracorpor-
eal circulation on the VA. Pressure measurement can be
either static, that is, with the blood pump stopped,13 or
dynamic when the pump is running.14 Static measurement
allows the direct assessment of intravascular pressures,15 but
its utility has been recently questioned.16 Dynamic measure
of venous access pressure17 is more sensitive to VA
dysfunctions and measurements of both arterial and venous
pressure improve stenosis detection.18
The method here proposed combines dynamic pressure
measurements in arterial and venous drip chambers with
access flow perturbation imposed by changing blood flow
shunted in the extracorporeal circulation. The method is
based on the intuitive idea that when the blood pump of
artificial kidney withdraws into the extracorporeal circulation
almost all the blood flow supplying the access, the flow in the
vessel portion between the arterial and venous needles is close
to zero. In this condition, the pressure drop Pf between
arterial (Paf) and venous (Pvf) needles should be practically
null. According to this idea, we estimated the pressure drop
Pf after imposing different blood pump flow rates and we
found that the Qb value at which Pf changes sign, that is QInv,
is quantitatively related to the Qa measured with Transonic
(see Figure 4). The correlation (R2¼ 0.72) between QInv and
Qa was higher (see Figure 3) than the one between Pf and Qa
evaluated in the case of blood pump stopped (static pressure
monitoring) and in the case of blood pump moving at a fixed
rate (dynamic pressure monitoring).
Although a high correlation between QInv and Qa data was
highlighted for the values of Qa higher than 800 ml/min, the
dispersion was larger for Qa less than 400 ml/min (see
Figure 4). Hence, a first indication of the QInv value consists
in classifying VA flow as ‘low’ or ‘high’, rather than providing
a precise estimation of Qa. In this study, a Qa higher than
500 ml/min is well predicted by a QInv4200 ml/min, whereas a
Qa lower than 500 ml/min is predicted by a QInvo200 ml/min.
P a
f [m
mH
g]
P v
f [m
mH
g]
35
30
25
20
15
Qb [ml/min]
0 50 100 150 200 250 300 350
P a
f-
P v
f [m
mH
g]
20
–20
–40
–60
0
0 50 100 150 200 250 300 350
Experimental
Simulated
0 50 100 150 200 250 300 350
30
15
–15
–30
0
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different extracorporeal blood flows (Qb).
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To confirm these results, additional data are needed, in terms
of both enlarging the number of patients studied and
extending the analysis to other types of needle sizes.
The surprising result was that the pressure Pf changed sign
for values of blood flow Qb less than patient Qa, thus the flow
QInv was a relatively small fraction of Qa (about 30%). To
explain this observation we resorted to CFD simulation that
allows the experimental conditions to be numerically mimed.
The comparison between simulated and experimental
pressures highlighted a good reliability, especially for Qb less
than 200 ml/min (see Figure 5). For Qb higher than 200 ml/
min, numerical prediction worsens because for such flow rates
the laminar hypothesis used in the numeric solver may be not
satisfied. Despite this aspect, it is worth noting that the
simulation confirms the experimental trend of Pf with respect
to the Qb changes. Importantly, the local pressure Paf and Pvf
are found to be influenced by the extracorporeal blood flow
Qb, as previously supposed
19 but never demonstrated by a
specific fluid dynamics analysis. CFD simulation makes clear
that when Qb rises over a critical threshold, the blood flow
through the venous return has difficulty to be drained into the
main vascular stream. In this condition, circulation in the
access is perturbed and a vortex occurs with a local increase of
pressure in the venous needle tip area (see Figure 6). On the
other hand, when VA does not properly supply the flow
withdrawal in the arterial needle pressure Paf tends to decrease.
Then, the increase of Qb above a critical value causes the Pf to
change from positive to negative with associated a VA
hemodynamics alteration. The critical value, that here was
estimated as QInv, depends on Qa amount as confirmed by the
high correlation, but it also depends on such factors as: the
inclination and size of needles, the compliance and reactivity
of vascular wall and the localization of obstruction. The latter
influences the sites were the laminar flow disruption takes
place: upstream of arterial needle in the case of proximal
obstruction and downstream of venous needle in the case of
distal obstruction. Importantly, for the same access flow Qa the
sites of the flow disturbance affect the QInv value differently. In
the case of distal obstruction, the QInv results lower than the
expected value by the regression line (equation in Figure 4).
Conversely, when the obstruction is between arterial and
venous needles, the extracorporeal circulation constitutes a
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Table 2 | Experimental parameters aj2, aj1, bj2, bj1, bj0 that
characterized the hydraulic resistance of venous (Rvm) and
arterial (Ram) bloodline
av2 av1 bv2 bv1 bvo
Venous needle 2*107 1.808*103 6.7*103 9.96*102 3.9073
aa2 aa1 ba2 ba1 ba0
Arterial needle 2*106 2.27*102 4.91*102 3.1644 58.348
The subscript j (=a, v) refers to arterial and venous bloodline.
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bypass for the obstruction, and suction and reinfusion flow are
not disturbed by the obstruction. In this case QInv could be
higher than the expected value. To validate these computa-
tional observations, a clinical study, comprising of subjects
with stenoses of different degree and location, should be done.
In this study, Pat02 and Pat04 can be considered as
exemplificative cases. Both patients underwent an access
failure because of a distal venous stenosis after the end of
study period. In Pat02, accordingly with the stenosis location,
both QInv determinations were lower than the expected value
(points under the dashed line correlation line in Figure 4). On
the contrary, Pat04 before the study initiation had an
obstruction between arterial and venous needle and at the
first study session the QInv was higher than the value estimated
by the correlation line (191 vs 126 ml/min). QInv determina-
tion was repeated 1 month before the access failure due to
distal stenosis and QInv was found critically low (9 ml/min) as
well as Qa (115 ml/min).
Importantly, CFD simulations show that when blood
pump flow rate overcomes QInv limit, flow separation takes
place with a dangerous transition from laminar to vortex
circulation (see Figure 6). Vortex as well as turbulent
circulation may sustain high levels of wall shear stress
(greater than the upper limit of 40 N/m2) that in long term
can lead to intimal hyperplasia, formation of aneurism, and
subsequent VA failure.20 In line with previous computational
studies,21 we predicted that vortex causes a severe increase of
shear stress (about 114 N/m2) on the wall in the face of the
needle tip. Therefore, the CFD simulations lead to an original
interpretation of QInv in term of the highest blood pump flow
rate to be approached to maximize the VA capability to
supply blood flow without involving flow disturbances and
the related critical vessel stress.
In conclusion, QInv could represent a novel bedside index
for monitoring VA adequacy. The optimal technique of VA
monitoring should not require any specific ability or nursing
staff nor time-consuming procedures that need to be
repeated on a regular basis, as is suggested by hemodialysis
guideline.3 QInv determination could be easily integrated into
the dialysis machine and non-invasively make online
measurements during the hemodialysis treatment.
MATERIALS AND METHODS
Subjects
A total of 16 chronic hemodialysis patients (40–83 years, 11 men and 5
women) were enrolled for this study, from the dialysis centers of San
Carlo Clinic in Paderno Dugnano (Milano, Italy) and of Polyclinic in
Monza (Milano, Italy). The investigation was done under the
responsibility of the principal medical investigator (RG) and all
participants signed informed consent. All patients had distal native
AVF as permanent VA and fistula patency was established by Echo
Color Doppler examination. In particular, vessel diameters, diastolic
peak velocity, and systolic peak velocity were in average 0.95±0.6 cm
(min–max: 0.4–1.9 cm), 0.31±0.22 cm/s (min–max: 0.1–0.6 cm/s), and
0.52±0.21 cm/s (min–max: 0.3–0.8 cm/s) respectively. Doppler analy-
sis before the study initiation showed only one case (patient 04) of
relevant obstruction between arterial and venous needle.
QInv estimation
Let us consider the pressure drop between arterial and venous VA
points
Pf ¼ Paf  Pvf ð1Þ
where Paf and Pvf indicate the intravascular blood pressures at the
arterial and venous needle tips, respectively. Under the simplifying
hypothesis of steady state flow in the VA, the pressure drop Pf
depends on the blood flow through the vessel (Qf) according to the
simple law
Pf ¼ Rf  Qf ð2Þ
where Rf is the hydraulic flow resistance of vessel segment between
arterial and venous puncture sites. Qf is equal to the access flow Qa,
that is, the flow upstream the arterial access point, minus the blood
flow Qb withdrawn in the extracorporeal circulation though the
arterial needle by the blood pump of dialysis machine. Then, Eq. 2
can be rewritten as
Pf ¼ Rf  ðQa  QbÞ ð3Þ
Eq. 3 states that if Rf is significantly greater than zero, then changes
of Qb cause measurable changes of Pf. It is worth noting that,
according to Eq. 3, Pf should tend to zero when Qb tends to Qa.
Consequently, the Qb value at which Pf becomes null, that we call
QInv, can be considered an indirect estimation of Qa. To determine
QInv, it is sufficient to measure Pf by imposing different Qb values
with blood pump and then to extrapolate the value of QInv from
such measures.
Actually, Paf and Pvf pressures are not directly measurable
but they can be estimated through a simple hydraulic model
of the extracorporeal bloodlines. According to this model we can
write:
Paf ¼ Pam þ Ram  Qb þ 0:76  DHart ð4Þ
Pvf ¼ Pvm  Rvm  ðQb  Quf Þ þ 0:76  DHven ð5Þ
where Pam and Pvm are the pressures measured in the arterial
and venous drip chambers, respectively; Ram and Rvm are the
hydraulic resistances of arterial and venous extracorporeal bloodline,
respectively, between the drip chambers and the needle tips. Quf
is the ultrafiltration rate, whereas the last terms in the Eqs. 4
and 5 represent the hydrostatic pressures due to the height
(DHart, DHven expressed in centimeters) of fluid column
between the level of blood in each drip chamber and the needle
tip. The coefficient 0.76 represents the hydrostatics pressure,
expressed in mm Hg, for each centimeter of fluid column and it is
equivalent to the product between the density of blood (1.055 g/
cm3) and the gravity acceleration. The need of this hydrostatic
correction was previously highlighted also by Polaschegg18 and
Besarab.19
As far as concerns the hydraulic resistances Ram and Rvm, they
were modeled as a function of the hematocrit level (Hct), blood flow
(Qb) and geometric dimensions of needle and bloodline by means of
the following empirical equation (subscripts a and v refer to arterial
and venous, respectively):
Rjm ¼ ðaj2  Qb2 þ aj1  Qb þ bj2  Hct2 þ bj1  Hct þ bj0Þ  Rpois ð6Þ
with j¼ a, v.
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RPois was computed by the Poiseuille’s law as follows:
Rpois ¼ 8  m0  Lp  R4 ¼ 0:0375 mm hg=ðml=minÞ ð7Þ
where m0 represents water viscosity at 25 1C and L and R are the
length and radius of needle and of the bloodline, respectively. The
values of the parameters aj2, aj1, bj2, bj1, bj0, with j¼ a, v are listed in
Table 2 and were identified by a laboratory ex vivo characterization.
In particular, bovine blood at different values of hematocrit was
made to circulate, in the extracorporeal circuit of Integra dialysis
machine (Gambro Dasco S.p.A., Medolla (MO), Italy), by using a 16
Gauge bore, medium length needle (16M Plume-S model; Hospal
Industrie, Meyzieu, France). Resistances Ram and Rvm were measured
by imposing different blood pump flows and parameters were then
estimated by best-fitting experimental data with Eq. 6.
Measurements of flow and pressures in the extracorporeal
circuit
Blood flow (Qb) used for the calculation was the one continuously
measured by Transonic (HD01plus; Transonic Systems Inc., Ithaca,
NY, USA) along the extracorporeal arterial lines, whereas Qbset was
manually set by acting on the knob of the hemodialysis machine.
Pressures Pam and Pvm were measured by high-accuracy pressure
sensors (SCX15DN; Honeywell International Inc., Morristown, NJ,
USA) connected to the drip chambers by additional disposable lines
(SP-221 model; Gambro Dasco S.p.A.). The blood pump rotation
induces a spurious oscillation on the pressure signals. The period of
such oscillation corresponds to the half period of pump revolution.
To remove this interference the time average of pressure signals over
three pump revolutions was computed. The revolution period was
detected by an infrared light sensor screwed to blood pump cover.
Time-average values of pressure signals were used as Pam and Pvm
data.
Signals were acquired in a laptop computer (Intel Pentium III,
clock 1200 MHz) equipped with an acquisition board (NI
DAQCard-6062E; National Instruments Co., Austin, TX, USA). A
dedicated LabVIEW (National Instruments Co.) software was used
to control acquisition, processing, visualization, and data entry.
Experimental procedure
Patients were treated with a dialysis machine Integra (Gambro
Dasco S.p.A.). The 16M Plume-S needles (Hospal Industrie) was
used to connect VA to extracorporeal circulation. Needles were
inserted along the same vessel, with arterial needle in countercurrent
and venous needle in cocurrent with respect to Qa.. To limit patients’
discomforts and to standardize the operations the following
protocol was applied: (1) Measurement of Qa and access recircula-
tion by Transonic according to manufacturing recommended
procedures10,11 at Qbset¼ 250 ml/min; (2) Setting of Quf at the
minimum value (100 ml/h); (3) Arterial and venous blood sampling
and hematocrit determination (Haematokrit by Hettich AG, Ba¨ch,
Switzerland); (4) Measurement of initial systolic and diastolic
arterial pressure, by a mercury sphygmomanometer (F. Bosch
Medizintechnik GmbH & Co. KG, Bisingen, Germany), and heart
rate; (5) Measurements of Pam, Pvm, and Qb at Qbset¼ 250, 50, 0, 50,
100, 150, 200, 250, 300, 350 ml/min. After each Qbset setting, before
data acquisition, it was awaited about 30 s for the stabilization of the
pressure signals. Moreover, for each Qbset value, DHart and DHven
values were manually measured; (6) Measurement of final systolic
and diastolic arterial pressure and heart rate; (7) Restoring the
prescribed UF rate. The procedure was done in the second hour of
dialysis.
Although the entire recording session lasted about 25 min, the
QInv, assessment procedure (Phase 5) required less than 8 min.
CFD simulations
Pressure and blood velocity distribution fields within the VA were
computed by CFD simulation software (FLUENT; Fluent Inc.,
Lebanon, NH, USA). The AVF was modeled as a cylindrical tube
with rigid walls. Its diameter was assigned equal to the vessel caliber
determined by ultrasound scan in the patient Pat01 (that is,
6.5 mm). The arterial and venous needle were considered inserted in
the upstream and downstream region of the conduct, respectively, at
a distance of about 10 cm and in such a way that an angle of 101 was
formed between the needle axis and the AVF axis (Figure 7). The
geometric model of the needle was based on the real dimensions of a
16 Gauge needle. Blood was assumed to be a homogenous,
incompressible and Newtonian fluid with density and viscosity
equal to 1.055 g/cm3 and 3.6e3 Pa  s, respectively according to
similar CFD studies. The inlet flow to the tube was equal to Qa flow
measured by Transonic in Pat01 (500 ml/min). Paf, Pvf, and blood
velocity field within the vessel were computed for different values of
Qb (0, 50, 100, 150, 200, 250, 300 ml/min).
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Figure 7 | Schematic view of bidimensional geometric model of arterial and venous needle insertion in the AVF used for the CFD
simulations. Symbols: Qb, blood flow in the extracorporeal circulation; Qa, access flow; Dv, AVF diameter.
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